Fortrea Holdings (FTRE) Intangibles (2022 - 2026)
Fortrea Holdings' (FTRE) quarterly Intangibles came in at $586.8 million in Q2 2026, down 10.32% on a YoY basis from $654.3 million in Q2 2025, and down 2.48% quarter-over-quarter from $601.7 million in Q1 2026.
Analysis
Fortrea Holdings (FTRE) Intangibles (2022 - 2026) Analysis & Trends
Fortrea Holdings (FTRE) has reported Intangibles for 5 consecutive years, with $586.8 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Intangibles fell 10.32% year-over-year to $586.8 million; the trailing twelve-month figure through Jun 2026 stood at $586.8 million (down 10.32% YoY), and the FY2025 full-year result was $622.0 million, down 5.14% from the prior year.
- Intangibles eased to $586.8 million in Q2 2026 per FTRE's latest filing, from $601.7 million in the prior quarter.
- Across five years, Intangibles topped out at $823.3 million in Q4 2022 and bottomed at $586.8 million in Q2 2026.
- Historically, Intangibles has averaged $687.5 million across 5 years, with a median of $673.4 million in 2024.
- The sharpest annual moves came in 2024 and 2025: Intangibles retreated 13.67% in 2024, then slipped 5.14% in 2025.
- Over 5 years, Intangibles stood at $823.3 million in 2022, then slipped by 11.56% to $728.1 million in 2023, then retreated by 9.94% to $655.7 million in 2024, then fell by 5.14% to $622.0 million in 2025, then dropped by 5.66% to $586.8 million in 2026.
- According to Business Quant data, Intangibles over the past three periods registered $586.8 million, $601.7 million, and $622.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.77 Bn | 40.69 Bn | 1.44 Bn | 4.75 Bn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 33.11 Mn |
| 3 | Charles River Laboratories International | 13.37 Bn | 13.18 Bn | 452.07 Mn | 253.17 Mn |
| 4 | Icon | 12.49 Bn | 11.56 Bn | 479.29 Mn | 3.15 Bn |
| 5 | Fortrea Holdings | 1.58 Bn | 1.42 Bn | 139.20 Mn | 586.80 Mn |
| 6 | Evotec SE | 642.83 Mn | 216.96 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 422.55 Mn | 338.02 Mn | 18.44 Mn | 44.39 Mn |
| 8 | Champions Oncology | 69.16 Mn | 69.16 Mn | 7.03 Mn | - |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn | - |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 586.80 Mn |
| Mar 31, 2026 | 601.70 Mn |
| Dec 31, 2025 | 622.00 Mn |
| Sep 30, 2025 | 635.40 Mn |
| Jun 30, 2025 | 654.30 Mn |
| Mar 31, 2025 | 651.30 Mn |
| Dec 31, 2024 | 655.70 Mn |
| Sep 30, 2024 | 691.20 Mn |
| Jun 30, 2024 | 691.90 Mn |
| Mar 31, 2024 | 707.90 Mn |
| Dec 31, 2023 | 728.10 Mn |
| Sep 30, 2023 | 773.70 Mn |
| Jun 30, 2023 | 801.50 Mn |
| Dec 31, 2022 | 823.30 Mn |